Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rank in Stocks #28154
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.40
Last synced: 2026-08-18
Market Cap
$28.25M
Change (1 day)
0.00%
Change (1 year)
536.36%
Country
IL
Trade Raphael Pharmaceutical Inc. (RAPH)

Category

Stock split history for Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. stock (symbol: RAPH) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One RAPH share bought prior to Aug 20, 2026 would equal to 0 RAPH shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors